COVID-19 and anosmia: The story so far

被引:19
|
作者
Meng, Xiangming [1 ]
Pan, Yuandan [2 ]
机构
[1] Wuxi Huishan Dist Peoples Hosp, Dept Otolaryngol, 2 Zhanqian North Rd, Wuxi 214187, Jiangsu, Peoples R China
[2] Wuxi Huishan Dist Peoples Hosp, Dept Resp Med, Wuxi, Jiangsu, Peoples R China
关键词
COVID-19; anosmia; olfactory dysfunction; SARS-CoV-2; smell; olfactory epithelium; olfactory bulb; OLFACTORY DYSFUNCTION;
D O I
10.1177/01455613211048998
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives The pandemic has affected over 182 million coronavirus disease 2019 (COVID-19) cases worldwide. Accumulated evidence indicates that anosmia is one of the significant characteristics of COVID-19 with a high prevalence. However, many aspects of COVID-19-induced anosmia are still far from being fully understood. The purpose of this review is to summarize recent developments in COVID-19-induced anosmia to increase awareness of the condition. Methods A literature search was carried out using the PubMed, Embase, Web of Science, and Scopus. We reviewed the latest literature on COVID-19-induced anosmia, including mechanisms of pathogenesis, olfactory testing, anosmia as predictive tool, pathological examinations, imaging findings, affected factors, co-existing diseases, treatments, prognosis, hypothesis theories, and future directions. Results The possible pathogenesis of COVID-19-induced anosmia may involve inflammation of the olfactory clefts and damage to the olfactory epithelium or olfactory central nervous system by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The D614G spike variant may also play a role in the increased number of anosmia patients. Anosmia may also be an essential indicator of COVID-19 spread and an early indicator of the effectiveness of political decisions. The occurrence and development of COVID-19-induced anosmia may be influenced by smoking behaviors and underlying diseases such as type 2 diabetes, gastroesophageal disorders, and rhinitis. Most patients with COVID-19-induced anosmia can fully or partially recover their olfactory function for varying durations. COVID-19-induced anosmia can be treated with various approaches such as glucocorticoids and olfactory training. Conclusion Anosmia is one of the main features of COVID-19 and the underlying disease of the patient may also influence its occurrence and development. The possible pathogenesis of COVID-19-induced anosmia is very complicated, which may involve inflammation of the olfactory clefts and damage to the olfactory epithelium or olfactory central nervous system.
引用
收藏
页码:NP312 / NP320
页数:9
相关论文
共 50 条
  • [1] Complement Inhibition and COVID-19: The Story so Far
    Fodil, Sofiane
    Annane, Djillali
    [J]. IMMUNOTARGETS AND THERAPY, 2021, 10 : 273 - 284
  • [2] Covid-19 and Papua New Guinea: The Story So Far
    Day, Benjamin
    [J]. ASIA POLICY, 2022, 17 (01): : 53 - 66
  • [3] COVID-19 anosmia
    Ovesen, Therese
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2020, 140 (07) : 624 - 624
  • [4] Neutrophils and COVID-19: The road so far
    Agra Cavalcante-Silva, Luiz Henrique
    Madruga Carvalho, Deyse Cristina
    Lima, Essia de Almeida
    Galvao, Jose G. F. M.
    de Franca da Silva, Juliane S.
    de Sales-Neto, Jose Marreiro
    Rodrigues-Mascarenhas, Sandra
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90
  • [5] Anosmia in the Era of COVID-19
    Besharat, Sima
    Amlashi, Fazel Isapanah
    Jahanshahi, Mehrdad
    Besharat, Mahsa
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2020, 13 (05)
  • [6] Anosmia in COVID-19 patients
    Hornuss, D.
    Lange, B.
    Schroeter, N.
    Rieg, S.
    Kern, W. V.
    Wagner, D.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (10) : 1426 - 1427
  • [7] Features of anosmia in COVID-19
    Klopfenstein, T.
    Kadiane-Oussou, N. J.
    Toko, L.
    Royer, P-Y
    Lepiller, Q.
    Gendrin, V
    Zayet, S.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (05): : 436 - 439
  • [8] COVID-19: Situation of European Countries so Far
    Pillai, Sunitha
    Siddika, Nazeeba
    Apu, Ehsanul Hoque
    Kabir, Russell
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (07) : 723 - 725
  • [9] Biologics in COVID-19 So Far: Systematic Review
    Arias, Milton
    Oliveros, Henry
    Lechtig, Sharon
    Bustos, Rosa-Helena
    [J]. PHARMACEUTICALS, 2022, 15 (07)
  • [10] Lessons (so far) from the COVID-19 pandemic
    Harvey, Edward J.
    [J]. CANADIAN JOURNAL OF SURGERY, 2021, 64 (01) : E108 - E108